Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
2017 · Nature Communications · 220 citations
https://doi.org/10.1038/s41467-017-00678-2
C
Cristina Papayannidis
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
622
Papers
6.9K
Citations
43
h-index
114
i10-index
Cristina Papayannidis is an academic researcher from IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 43, co-authored 529 publications.
ORCID: 0000-0001-8705-8333Papers by this author
worksA Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
2015 · Blood Cancer Journal · 117 citations
https://doi.org/10.1038/bcj.2015.80
Chromothripsis in acute myeloid leukemia: biological features and impact on survival
2018 · Leukemia · 111 citations
https://doi.org/10.1038/s41375-018-0035-y
A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
2014 · Blood Cancer Journal · 64 citations
https://doi.org/10.1038/bcj.2014.60
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
2018 · Journal of Hematology & Oncology · 56 citations
https://doi.org/10.1186/s13045-018-0641-1
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
2021 · Annals of Hematology · 53 citations
https://doi.org/10.1007/s00277-021-04465-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat